Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - CALADRIUS BIOSCIENCES, INC. | v232807_8-k.htm |
| EX-99.1 - PRESS RELEASE - CALADRIUS BIOSCIENCES, INC. | v232807_ex99-1.htm |
August 18, 2011
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of NeoStem, Inc.’s Form 8-K dated August 12, 2011, and have the following comments:
|
|
1.
|
We agree with the statements made in the first, second, third and fifth paragraphs.
|
|
|
2.
|
We have no basis on which to agree or disagree with the statements made in the fourth paragraph.
|
Yours truly,
/s/ DELOITTE & TOUCHE LLP
Parsippany, New Jersey